Biosimilar medicines can generate savings to the society. However, if patient access to original biologic medicines is limited, the main benefit of biosimilar medicines is to treat more patients from the same health care budget and hence generate more health gain.
No takes yet. Share an insight, caveat, or question.
Inotai et al. (2017) studied this question.